Alembic releases generic CosoptGeneric Cosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. Celltrion launches Stelara biosimilarSteqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well as Crohn's disease and ulcerative colitis in adult patients. Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval. Mallinckrodt and Endo to merge Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the transaction. Biocon Biologics, Civica collaborate to expand insulin Aspart access Biocon Biologics will supply Insulin Aspart drug substance to Civica, who will use the drug substance to produce Insulin Aspart drug product. FDA approves Celltrion's Xolair biosimilar Omlyclo is used for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, immunoglobulin E-mediated food allergy and chronic spontaneous urticaria. AAM commends Q1/Q2 House Bill reintroduction AAM said the bill will cut red tape, bring lower-cost medicines to patients faster and save money. Lupin launches generic Xarelto Rivaroxaban tablets are used to reduce the risk of major cardiovascular events in patients with CAD. Elite Pharmaceuticals ships first product from new facility, packaging line The new facility Northvale, N.J., includes packaging, inventory and warehouse space. Axsome Therapeutics settles Sunosi patent litigation with Hikma Axsome will grant Hikma a license to sell its generic version of Sunosi. First Previous 4 5 6 7 8 Next Last
